| NCT ID | NCT02834013 |
| Title | Nivolumab and Ipilimumab in Treating Patients With Rare Tumors |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase 0 |
| Variant Requirements | No |
| Sponsors | National Cancer Institute (NCI) |
| Indications |
testicular non-seminomatous germ cell cancer gastric neuroendocrine neoplasm scrotum squamous cell carcinoma pancreatic acinar cell adenocarcinoma peripheral nerve sheath neoplasm placental site trophoblastic tumor gastric squamous cell carcinoma ovarian squamous cell carcinoma ovarian mucinous adenocarcinoma testicular sex cord-stromal neoplasm ureter squamous cell carcinoma pulmonary neuroendocrine tumor cervical squamous cell carcinoma small intestine adenocarcinoma urethra squamous cell carcinoma peritoneal serous adenocarcinoma gastrointestinal neuroendocrine tumor intrahepatic cholangiocarcinoma bronchiolo-alveolar adenocarcinoma adrenal gland pheochromocytoma |
| Therapies | |
| Age Groups: | adult senior |